What is the share price of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) today?
The share price of SOLARAPP1 as on 13th June 2025 is ₹362. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) share?
The past returns of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) share are- Past 1 week: 3.48%
- Past 1 month: -8.23%
- Past 3 months: 48.67%
- Past 6 months: -22.73%
- Past 1 year: 71.19%
- Past 3 years: N/A%
- Past 5 years: 71.19%
What are the peers or stocks similar to Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1)?
The peers or stocks similar to Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) include:What is the 52 week high and low of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) share?
The 52-week high of Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) is ₹554.95 and the 52-week low is ₹200.Which sector does Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) belong to?
Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) belongs to the Unknown sector & N/A sub-sector.How to buy Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) shares?
You can directly buy Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Solara Active Pharma Sciences Ltd Partly Paidup
SOLARAPP1 Share Price
362.001.12% (-4.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SOLARAPP1 Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
BadInsufficient Data
Red flags
LowNo red flag found
How to use scorecard? Learn more
SOLARAPP1 Performance & Key Metrics
SOLARAPP1 Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | — | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 0 | 0 | — |
SOLARAPP1 Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SOLARAPP1 Company Profile
Hmm, looks like data is unavailable here. Please come back after some timeSUNPHARMA
PE Ratio
37.04
37.04
1Y Return
11.98%
11.98%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.02
23.02
1Y Return
2.48%
2.48%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
20.05
20.05
1Y Return
12.43%
12.43%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
57.71
57.71
1Y Return
12.62%
12.62%
Buy Reco %
72.00
72.00
MANKIND
PE Ratio
49.54
49.54
1Y Return
7.41%
7.41%
Buy Reco %
81.25
81.25
SOLARAPP1 Sentiment Analysis
SOLARAPP1 Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
SOLARAPP1 Stock Summary · January 2025
The company is currently grappling with revenue challenges due to heightened pricing competition, yet it has achieved a notable gross margin expansion of 500 basis points, reflecting improved operational efficiency. While the CRAMS segment has underperformed, it is projected to deliver significantly higher margins, supported by strategic investments in the FDA-approved Vizag facility. Management remains optimistic about long-term growth, targeting mid-single-digit revenue increases for FY '25 and aiming for a substantial rise in the pharmaceutical polymers sector. Despite operational hurdles and a downward revision in revenue guidance, the focus on debt reduction and maintaining a healthy balance sheet positions the company favorably for sustainable growth in a competitive landscape.
SOLARAPP1 Stock Growth Drivers
SOLARAPP1 Stock Growth Drivers
5Margin Expansion and Financial Health
The company has achieved a gross margin expansion of 500 basis points, resulting in improved
Strategic Focus on CRAMS Business
The company is strategically focusing on its CRAMS (Contract Research and Manufacturing Services) business, which
SOLARAPP1 Stock Challenges
SOLARAPP1 Stock Challenges
5Disappointing Revenue Performance
The company reported a disappointing quarter with a decline in revenue attributed to increased pricing
Debt Management Challenges
The company has made progress in reducing its debt, now standing at approximately 2.5 times
SOLARAPP1 Forecast
SOLARAPP1 Forecasts
Price
Revenue
Earnings
SOLARAPP1 Company Revenue Forecast
SOLARAPP1 Company Revenue Forecast
NaN
Current
₹—
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
NaN
Current
₹—
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
SOLARAPP1
SOLARAPP1
Income
Balance Sheet
Cash Flow
Annual Normal View
SOLARAPP1 Income Statement
SOLARAPP1 Income Statement
Annual Normal View
| Financial Year | TTM | |
|---|---|---|
| Total Revenue | — | |
Raw Materials | — | |
| Power & Fuel Cost | ||
| Employee Cost | ||
| Selling & Administrative Expenses | ||
| Operating & Other expenses | ||
EBITDA | — | |
| Depreciation/Amortization | — | |
| PBIT | — | |
| Interest & Other Items | — | |
| PBT | — | |
| Taxes & Other Items | — | |
| Net Income | — | |
| EPS | — | |
| DPS | — | |
| Payout ratio | — |
SOLARAPP1 Company Updates
SOLARAPP1 Stock Peers
SOLARAPP1 Past Performance & Peer Comparison
SOLARAPP1 Past Performance & Peer Comparison
Comparing 3 stocks from
UnknownPharmaceuticals
Compare valuation on Screener
UnknownPharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Solara Active Pharma Sciences Ltd Partly Paidup | — | — | — |
| Sun Pharmaceutical Industries Ltd | 37.04 | 6.03 | 0.95% |
| Cipla Ltd | 23.02 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.05 | 4.01 | 0.59% |
SOLARAPP1 Stock Price Comparison
Compare SOLARAPP1 with any stock or ETFCompare SOLARAPP1 with any stock or ETF
SOLARAPP1
SOLARAPP1 Holdings
SOLARAPP1 Shareholdings
SOLARAPP1 Promoter Holdings Trend
SOLARAPP1 Promoter Holdings Trend
No promoter holdings trend are available
SOLARAPP1 Institutional Holdings Trend
SOLARAPP1 Institutional Holdings Trend
No institutional holdings trend are available
SOLARAPP1 Shareholding Pattern
SOLARAPP1 Shareholding Pattern
Hmm, looks like data is currently unavailable. Once it’s updated, you can view it hereSOLARAPP1 Shareholding History
SOLARAPP1 Shareholding History
Hmm, looks like data is currently unavailable. Once it’s updated, you can view it hereHmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SOLARAPP1 stock
smallcases containing SOLARAPP1 stock
Looks like this stock is not in any smallcase yet.
SOLARAPP1 Events
SOLARAPP1 Events
SOLARAPP1 Dividend Trend
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SOLARAPP1 Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SOLARAPP1 has not given any dividends in last 5 years
SOLARAPP1 Dividends
SOLARAPP1 Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSOLARAPP1 Stock News & Opinions
SOLARAPP1 Stock News & Opinions
Articles & Videos
Corporate
Solara Active PharmaSci.-PartlyPaidup AGM scheduled
Solara Active PharmaSci.-PartlyPaidup announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
SOLARAPP1 has not given any dividends in last 5 years